YELENA SAVITSKAYA: Open Payments
NPI 1780465542 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,248 in 87 payments from 22 companies in 2025. Trend: 2023 $40 · 2024 $1,531 · 2025 $2,248
Food & beverage: $2,248
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $326 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $241 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $204 |
| ABBVIE INC. | 3 | $171 |
| Gilead Sciences, Inc. | 7 | $167 |
| Astellas Pharma US Inc | 6 | $153 |
| Esperion Therapeutics, Inc. | 7 | $140 |
| Abbott Laboratories | 2 | $101 |
| ViiV Healthcare Company | 4 | $92 |
| Lilly USA, LLC | 4 | $92 |
Products named: AIRSUPRA, Kerendia, JARDIANCE, Veozah, QULIPTA, NEXLETOL, FREESTYLE LIBRE 3, APRETUDE.
Industry payments across NY — which companies pay providers there.
